DiaMedica begins Phase II trial to treat acute ischemic stroke

US-based biopharmaceutical firm DiaMedica Therapeutics has begun a Phase II clinical trial (REMEDY) of its therapeutic candidate DM199 for the treatment of patients with acute ischemic stroke.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news